Get the Stockscreener App
0.00
100.00%
-0.2001
Unity Biotechnology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
See More
Previous Close:
$0.2001
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$13.94M
Revenue:
-
Net Income/Loss:
$-52.53M
P/E Ratio:
0.00
EPS:
-3.66
Net Cash Flow:
$-39.93M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
Name
Unity Biotechnology Inc
Sector
Industry
Phone
(650) 416-1192
Address
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Compare UBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.73 | 105.80B | 11.70B | 3.68B | 3.50B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
649.04 | 67.70B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
439.00 | 57.41B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.57 | 51.25B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.63 | 39.86B | 447.02M | -1.18B | -906.14M | -6.1812 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-16-25 | Downgrade | Mizuho | Outperform → Neutral |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-16-23 | Upgrade | Wedbush | Neutral → Outperform |
| Jan-04-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Nov-10-21 | Upgrade | Mizuho | Neutral → Buy |
| Jun-28-21 | Upgrade | Citigroup | Sell → Buy |
| Jun-07-21 | Initiated | H.C. Wainwright | Buy |
| Feb-16-21 | Downgrade | Citigroup | Neutral → Sell |
| Aug-18-20 | Downgrade | Citigroup | Buy → Neutral |
| Aug-18-20 | Downgrade | Mizuho | Buy → Neutral |
| Aug-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-17-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-28-20 | Initiated | ROTH Capital | Buy |
| Dec-12-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-19 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Initiated | Mizuho | Buy |
| May-29-18 | Initiated | Citigroup | Buy |
| May-29-18 | Initiated | Goldman | Neutral |
| May-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Unity Biotechnology Inc Stock (UBX) Latest News
Why Unity Biotechnology Inc. stock is a value investor pickQuarterly Portfolio Review & Fast Gain Stock Trading Tips - fcp.pa.gov.br
Is Unity Biotechnology Inc. stock supported by strong fundamentals2025 Bull vs Bear & Daily Entry Point Trade Alerts - newser.com
Best data tools to analyze Unity Biotechnology Inc. stock2025 Earnings Surprises & Safe Entry Point Alerts - newser.com
Why Unity Biotechnology Inc. stock attracts global investorsTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Ranking Unity Biotechnology Inc. among high performing stocks via toolsMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Combining price and volume data for Unity Biotechnology Inc.2025 Technical Overview & Free Risk Controlled Daily Trade Plans - newser.com
Risk vs reward if holding onto Unity Biotechnology Inc.July 2025 Gainers & Safe Entry Trade Signal Reports - newser.com
Should you wait for a breakout in Unity Biotechnology Inc.Weekly Investment Recap & Risk Controlled Daily Trade Plans - newser.com
Will Unity Biotechnology Inc. stock go up soonForecast Cut & Daily Technical Forecast Reports - newser.com
Can Unity Biotechnology Inc. stock deliver strong Q4 earningsMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Key resistance and support levels for Unity Biotechnology Inc.July 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
Is Unity Biotechnology Inc. stock attractive after correction2025 Major Catalysts & Verified High Yield Trade Plans - newser.com
Working capital per share of Unity Biotechnology, Inc. – BER:9U90 - TradingView
Net current asset value per share of Unity Biotechnology, Inc. – GETTEX:9U90 - TradingView
Heatmap analysis for Unity Biotechnology Inc. and competitors2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com
Unity Biotechnology Inc Stock (UBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.18%
1.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):